Skip to main content

Advertisement

SpringerLink
Log in

Medical and surgical management of the pediatric patient with intestinal failure

  • Published:
Current Treatment Options in Gastroenterology Aims and scope Submit manuscript

Opinion statement

Until recently, extreme short bowel due primarily to massive resection in the neonatal period had been considered incompatible with long-term survival. Indeed, parents of infants with midgut volvulus or other causes of very extensive intestinal necrosis still may be informed that resection is futile. The advent of intestinal transplantation as a potential therapy and its evolution into a standard therapy for irreversible intestinal failure have led to changing attitudes regarding these catastrophic gastrointestinal events. The experience gained from aggressively maintaining infants with little if any functional small bowel while awaiting transplantation has led to the increasing recognition that long-term survival is possible in many of these children with and often without intestinal transplantation. Even children with very small lengths of residual intestine ultimately may adapt and grow sufficiently to allow enteral autonomy. Achievement of these outcomes requires early referral to a dedicated multidisciplinary intestinal care team well versed in the management options for such children. Initial assessment often involves an inpatient evaluation followed by very close outpatient follow-up. Aggressive management is imperative for all patients with intestinal failure, allowing time for full enteral adaptation before complications become life-threatening; those with no possibility of significant adaptation can achieve optimal growth while awaiting transplantation. Along with medical and nutritional therapy and nontransplant surgery, intestinal transplantation should be seen as one of many modalities available for the optimal management of this population of patients. Thus, patients with irreversible intestinal failure and those with indications for transplantation (even those for whom hope remains that sufficient enteral adaptation still may occur) should be evaluated by the transplant team. If there is no intestinal transplant program at the center undertaking the intestinal failure management, strong links and regular communication with an intestinal transplant program that can partner in the care of these patients should be established. Multicenter collaborative and interventional studies are necessary to clearly demonstrate outcomes and to move the field forward.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Goulet O, Baglin-Gobet S, Talbotec C, et al.: Outcome and long-term growth after extensive small bowel resection in the neonatal period: a survey of 87 children. Eur J Pediatr Surg 2005, 15:95–101.

    Article  PubMed  CAS  Google Scholar 

  2. Drozdowski L, Thomson AB: Intestinal mucosal adaptation. World J Gastroenterol 2006, 12:4614–4627.

    PubMed  Google Scholar 

  3. Tavakkolizadeh A, Whang EE: Understanding and augmenting human intestinal adaptation: a call for more clinical research. JPEN J Parenter Enteral Nutr 2002, 26:251–255.

    PubMed  Google Scholar 

  4. DiBaise JK, Young RJ, Vanderhoof JA: Intestinal rehabilitation and the short bowel syndrome: part 1. Am J Gastroenterol 2004, 99:1386–1395.

    Article  PubMed  Google Scholar 

  5. DiBaise JK, Young RJ, Vanderhoof JA: Intestinal rehabilitation and the short bowel syndrome: part 2. Am J Gastroenterol 2004, 99:1823–1832.

    Article  PubMed  Google Scholar 

  6. Jeppesen PB, Mortensen PB: The influence of a preserved colon on the absorption of medium chain fat in patients with small bowel resection. Gut 1998, 43:478–483.

    Article  PubMed  CAS  Google Scholar 

  7. Buchman AL: Etiology and initial management of short bowel syndrome. Gastroenterology 2006, 130(Suppl 1):S5–S15.

    Article  PubMed  CAS  Google Scholar 

  8. Ament ME: Bone mineral content in patients with short bowel syndrome: the impact of parenteral nutrition. J Pediatr 1998, 132:386–388.

    Article  PubMed  CAS  Google Scholar 

  9. Goulet O, Ruemmele F: Causes and management of intestinal failure in children. Gastroenterology 2006, 130(Suppl 1):S16–S28.

    Article  PubMed  CAS  Google Scholar 

  10. O’Keefe SJ: Bacterial overgrowth and liver complications in short bowel intestinal failure patients. Gastroenterology 2006, 130(Suppl 1):S67–S69.

    Article  PubMed  Google Scholar 

  11. Teitelbaum DH: Parenteral nutrition-associated cholestasis. Curr Opin Pediatr 1997, 9:270–275.

    Article  PubMed  CAS  Google Scholar 

  12. Terra RM, Plopper C, Waitzberg DL, et al.: Remaining small bowel length: association with catheter sepsis in patients receiving home total parenteral nutrition: evidence of bacterial translocation. World J Surg 2000, 24:1537–1541.

    Article  PubMed  CAS  Google Scholar 

  13. Zheng YJ, Tam YK, Coutts RT: Endotoxin and cytokine released during parenteral nutrition. JPEN J Parenter Enteral Nutr 2004, 28:163–168.

    Article  PubMed  CAS  Google Scholar 

  14. Azhar SS, Beach RE: D-lactic acidosis in a diabetic patient with a short bowel. J Am Board Fam Pract 2002, 15:316–318.

    PubMed  Google Scholar 

  15. Kemp R, Correia RB, Sankarankutty AK, et al.: Liver disease associated with intestinal failure in the small bowel syndrome [in Portuguese]. Acta Cir Bras 2006, 21:67–71.

    Article  PubMed  Google Scholar 

  16. Kelly DA: Liver complications of pediatric parenteral nutrition—epidemiology. Nutrition 1998, 14:153–157.

    Article  Google Scholar 

  17. Kelly DA: Intestinal failure-associated liver disease: what do we know today? Gastroenterology 2006, 130(Suppl 1):S70–S77.

    Google Scholar 

  18. Shulman RJ: New developments in total parenteral nutrition for children. Curr Gastroenterol Rep 2000, 2:253–258.

    Article  PubMed  CAS  Google Scholar 

  19. Baker S, Baker R: Parenteral Nutrition, edn 4, vol 2. Ontario, British Columbia: Decker; 2004.

    Google Scholar 

  20. Asheim P, Uggen PE, Aasarod K, Aadahl P: Intraperitoneal fluid therapy: an alternative to intravenous treatment in a patient with limited vascular access. Anaesthesia 2006, 61:502–504.

    Article  PubMed  CAS  Google Scholar 

  21. Lang EV, Reyes J, Faintuch S, et al.: Central venous recanalization in patients with short gut syndrome: restoration of candidacy for intestinal and multivisceral transplantation. J Vasc Interv Radiol 2005, 16:1203–1213.

    PubMed  Google Scholar 

  22. Rodrigues AF, van Mourik ID, Sharif K, et al.: Management of end-stage central venous access in children referred for possible small bowel transplantation. J Pediatr Gastroenterol Nutr 2006, 42:427–433.

    Article  PubMed  CAS  Google Scholar 

  23. DiBaise JK, Young RJ, Vanderhoof JA: Enteric microbial flora, bacterial overgrowth, and short-bowel syndrome. Clin Gastroenterol Hepatol 2006, 4:11–20.

    Article  PubMed  Google Scholar 

  24. Eizaguirre I, Urkia NG, Asensio AB, et al.: Probiotic supplementation reduces the risk of bacterial translocation in experimental short bowel syndrome. J Pediatr Surg 2002, 37:699–702.

    Article  PubMed  CAS  Google Scholar 

  25. Uchida K, Takahashi T, Inoue M, et al.: Immunonutritional effects during synbiotics therapy in pediatric patients with short bowel syndrome. Pediatr Surg Int 2007, 23:243–248.

    Article  PubMed  Google Scholar 

  26. Iyer KR, Horslen S, Torres C, et al.: Functional liver recovery parallels autologous gut salvage in short bowel syndrome. J Pediatr Surg 2004, 39:340–344.

    Article  PubMed  CAS  Google Scholar 

  27. Teitelbaum DH, Tracy TF, Jr, Aouthmany MM, et al.: Use of cholecystokinin-octapeptide for the prevention of parenteral nutrition-associated cholestasis. Pediatrics 2005, 115:1332–1340.

    Article  PubMed  Google Scholar 

  28. De Marco G, Sordino D, Bruzzese E, et al.: Early treatment with ursodeoxycholic acid for cholestasis in children on parenteral nutrition because of primary intestinal failure. Aliment Pharmacol Ther 2006, 24:387–394.

    Article  PubMed  CAS  Google Scholar 

  29. Barksdale EM, Stanford A: The surgical management of short bowel syndrome. Curr Gastroenterol Rep 2002, 4:229–237.

    Article  PubMed  Google Scholar 

  30. Benedetti E, Panaro F, Holterman M, Abcarian H: Surgical approaches and intestinal transplantation. Best Pract Res Clin Gastroenterol 2003, 17:1017–1040.

    Article  PubMed  Google Scholar 

  31. Bianchi A: Intestinal loop lengthening—a technique for increasing small intestinal length. J Pediatr Surg 1980, 15:145–151.

    Article  PubMed  CAS  Google Scholar 

  32. Goulet O, Ruemmele F, Lacaille F, Colomb V: Irreversible intestinal failure. J Pediatr Gastroenterol Nutr 2004, 38:250–269.

    Article  PubMed  Google Scholar 

  33. Bianchi A: Longitudinal intestinal lengthening and tailoring: results in 20 children. J R Soc Med 1997, 90:429–432.

    PubMed  CAS  Google Scholar 

  34. Hosie S, Loff S, Wirth H, et al.: Experience of 49 longitudinal intestinal lengthening procedures for short bowel syndrome. Eur J Pediatr Surg 2006, 16:171–175.

    Article  PubMed  CAS  Google Scholar 

  35. Sudan D, DiBaise J, Torres C, et al.: A multidisciplinary approach to the treatment of intestinal failure. J Gastrointest Surg 2005, 9:165–176. Discussion 176–177.

    Article  PubMed  Google Scholar 

  36. Bianchi A: From the cradle to enteral autonomy: the role of autologous gastrointestinal reconstruction. Gastroenterology 2006, 130(Suppl 1):S138–S146.

    Article  PubMed  Google Scholar 

  37. Figueroa-Colon R, Harris PR, Birdsong E, et al.: Impact of intestinal lengthening on the nutritional outcome for children with short bowel syndrome. J Pediatr Surg 1996, 31:912–916.

    Article  PubMed  CAS  Google Scholar 

  38. Kim HB, Fauza D, Garza J, et al.: Serial transverse enteroplasty (STEP): a novel bowel lengthening procedure. J Pediatr Surg 2003, 38:425–429.

    Article  PubMed  Google Scholar 

  39. Duggan C, Piper H, Javid PJ, et al.: Growth and nutritional status in infants with short-bowel syndrome after the serial transverse enteroplasty procedure. Clin Gastroenterol Hepatol 2006, 4:1237–1241.

    Article  PubMed  Google Scholar 

  40. Kato T, Mittal N, Nishida S, et al.: The role of intestinal transplantation in the management of babies with extensive gut resections. J Pediatr Surg 2003, 38:145–149.

    Article  PubMed  Google Scholar 

  41. Kaufman SS, Atkinson JB, Bianchi A, et al.: Indications for pediatric intestinal transplantation: a position paper of the American Society of Transplantation. Pediatr Transplant 2001, 5:80–87.

    Article  PubMed  CAS  Google Scholar 

  42. Horslen S, Barr ML, Christensen LL, et al.: Pediatric transplantation in the United States, 1996–2005. Am J Transplant 2007, 7(Suppl 1):1339–1358.

    Article  PubMed  CAS  Google Scholar 

  43. Botha JF, Grant WJ, Torres C, et al.: Isolated liver transplantation in infants with end-stage liver disease due to short bowel syndrome. Liver Transpl 2006, 12:1062–1066.

    Article  PubMed  Google Scholar 

  44. Baksheev L, Fuller PJ: Humoral factors in intestinal adaptation. Trends Endocrinol Metab 2000, 11:401–405.

    Article  PubMed  CAS  Google Scholar 

  45. Drucker DJ: Biologic actions and therapeutic potential of the proglucagon-derived peptides. Nat Clin Pract Endocrinol Metab 2005, 1:22–31.

    Article  PubMed  CAS  Google Scholar 

  46. Estall JL, Drucker DJ: Glucagon and glucagon-like peptide receptors as drug targets. Curr Pharm Des 2006, 12:1731–1750.

    Article  PubMed  CAS  Google Scholar 

  47. Iskit SH, Tugtepe H, Ayyildiz SH, et al.: Epidermal growth factor and bombesin act synergistically to support intestinal adaptation in rats with massive small bowel resection. Pediatr Surg Int 2005, 21:436–440.

    Article  PubMed  Google Scholar 

  48. Knott AW, Erwin CR, Profitt SA, et al.: Localization of postresection EGF receptor expression using laser capture microdissection. J Pediatr Surg 2003, 38:440–445.

    Article  PubMed  Google Scholar 

  49. Johnson WF, DiPalma CR, Ziegler TR, et al.: Keratinocyte growth factor enhances early gut adaptation in a rat model of short bowel syndrome. Vet Surg 2000, 29:17–27.

    Article  PubMed  CAS  Google Scholar 

  50. Kohl M, Wedel T, Entenmann A, et al.: Influence of different intravenous lipid emulsions on hepatobiliary dysfunction in a rabbit model. J Pediatr Gastroenterol Nutr 2007, 44:237–244.

    Article  PubMed  CAS  Google Scholar 

  51. Gupta A, Dixit A, Sales KM, et al.: Tissue engineering of small intestine—current status. Biomacromolecules 2006, 7:2701–2709.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Children’s Hospital Regional Medical Center, Seattle, WA, 98105, USA

    Frances R. Malone

Authors
  1. Frances R. Malone
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Simon P. Horslen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Frances R. Malone.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Malone, F.R., Horslen, S.P. Medical and surgical management of the pediatric patient with intestinal failure. Curr Treat Options Gastro 10, 379–390 (2007). https://doi.org/10.1007/s11938-007-0038-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11938-007-0038-7

Keywords

Search

Navigation